NCT02310997 Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) Status TERMINATED Phase PHASE2
NCT02308527 Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children Status COMPLETED Phase PHASE2
NCT02306161 Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02303821 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT02299999 SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02298946 AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT02298348 Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02298283 Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD Status COMPLETED Phase PHASE2
NCT02294552 Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT Status COMPLETED Phase PHASE2
NCT02293109 Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma Status COMPLETED Phase PHASE1
NCT02287311 Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02285062 Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE3
NCT02282904 Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide Status TERMINATED Phase PHASE1/PHASE2
NCT02282514 Stem Cell Transplantation for Stiff Person Syndrome (SPS) Status TERMINATED Phase PHASE1/PHASE2
NCT02280811 T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT02278887 Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma Status COMPLETED Phase PHASE3